Environmental enrichment exerts neuroprotective effects on cerebral ischemia-reperfusion injury with the ALK5/Smad2/3/Gadd45β pathway involved in the inhibition of apoptosis
Reperfusion therapy is the primary treatment for ischemic stroke; however, it can induce cerebral ischemia–reperfusion injury (CIRI), often leading to suboptimal neurological recovery. Combining reperfusion with neuroprotective interventions such as environmental enrichment (EE) to suppress reperfusion-induced cellular damage holds significant therapeutic promise. This study mainly focused on the activin receptor-like kinase 5 (ALK5) signaling pathway to explore the potential regulatory mechanism of EE in mediating neuroprotection and functional repair following CIRI. In vivo experiments were performed using transient middle cerebral artery occlusion/reperfusion (tMCAO/R) rat models. In vitro validation was conducted in oxygen-glucose deprivation/reoxygenation (OGD/R) treated SH-SY5Y cells. Combined genetic interventions, including ALK5 overexpression, ALK5 knockdown, and growth arrest and DNA damage-inducible 45 β (Gadd45β) silencing, were applied to verify the potential molecular mechanism. The results showed that EE significantly upregulated ALK5 expression in the ipsilesional cerebral cortex (M1 region) within the ischemic penumbra, reduced neurological deficits, and reduced the abundance of apoptosis-related markers and TUNEL-positive cells. Mechanistically, ALK5 overexpression was associated with increased phosphorylation of downstream Smad2/3 and elevated Gadd45β expression. Further intervention experiments demonstrated that ALK5 knockdown aggravated neurological deficits, whereas ALK5 overexpression recapitulated the neuroprotective phenotypes observed with EE. Moreover, Gadd45β silencing reversed the modulation of apoptosis-related markers induced by the EE/ALK5 signaling axis. In conclusion, this study reveals a novel potential neuroprotective mechanism in which the ALK5/Smad2/3/Gadd45β signaling cascade may contribute to EE-mediated amelioration of CIRI. It provides theoretical support for the clinical translation of EE as an adjuvant rehabilitative strategy for stroke, and suggests that the ALK5 signaling pathway may serve as a promising therapeutic target for improving neurological recovery following CIRI.
Authors
- 张克明 (ORCID: https://orcid.org/0009-0001-1378-5340)
- Lingyi Liao (ORCID: https://orcid.org/0000-0003-1416-5896)
- Lin Lv
- Qingyi Lu (ORCID: https://orcid.org/0000-0003-0738-8725)
- Xia Jiang
- Gang Liu
- Lu Liu
- Yuanyuan Song
- Yuqi Zou
- Hongmei Xiao
- Changyue Gao
Institutions
- Army Medical University (CN)
- Chongqing University (CN)
- Daping Hospital (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Medical and Pharmaceutical College (CN)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1038/s41598-026-79389-y
- Primary Topic
- Neuroprotection in Cerebral Ischemia
- Type
- article
- Field-Weighted Citation Impact
- 0.00